about
Modafinil as a catecholaminergic agent: empirical evidence and unanswered questionsFuture pharmacological treatments for substance use disordersNonhuman primate positron emission tomography neuroimaging in drug abuse researchDopamine transporter-related effects of modafinil in rhesus monkeys.Modafinil blocks reinstatement of extinguished opiate-seeking in rats: mediation by a glutamate mechanismNeuroimaging and drug taking in primatesSleep abnormalities associated with alcohol, cannabis, cocaine, and opiate use: a comprehensive reviewPharmacotherapy for stimulant-related disordersBehavioral, biological, and chemical perspectives on atypical agents targeting the dopamine transporterAstrocytic dysfunction and addiction: consequences of impaired glutamate homeostasisRole of nucleus accumbens glutamatergic plasticity in drug addictionAgonist replacement for stimulant dependence: a review of clinical researchCommon and distinct neural targets of treatment: changing brain function in substance addictionPsychostimulant treatment of cocaine dependenceEffects of chronic binge-like ethanol consumption on cocaine self-administration in rhesus monkeys.Monoamine transporter inhibitors and substrates as treatments for stimulant abuseReward processing in autism: a thematic series.Noribogaine reduces nicotine self-administration in rats.Receptor-Based Discovery of a Plasmalemmal Monoamine Transporter Inhibitor via High Throughput Docking and Pharmacophore Modeling.Preliminary evidence for normalization of risk taking by modafinil in chronic cocaine users.Randomized, double-blind, placebo-controlled trial of modafinil for the treatment of methamphetamine dependence.Pharmacological approaches to methamphetamine dependence: a focused review.Cocaine Addiction Treatments to improve Control and reduce Harm (CATCH): new pharmacological treatment options for crack-cocaine dependence in the NetherlandsTreatment with modafinil and escitalopram, alone and in combination, on cocaine-induced effects: a randomized, double blind, placebo-controlled human laboratory study.Novel pharmacotherapeutic treatments for cocaine addiction.A placebo-controlled trial of memantine for cocaine dependence with high-value voucher incentives during a pre-randomization lead-in period.Cognitive enhancers in the treatment of substance use disorders: clinical evidence.Pharmacotherapeutics directed at deficiencies associated with cocaine dependence: focus on dopamine, norepinephrine and glutamate.Pharmacologically-mediated reactivation and reconsolidation blockade of the psychostimulant-abuse circuit: a novel treatment strategy.Sustained release d-amphetamine reduces cocaine but not 'speedball'-seeking in buprenorphine-maintained volunteers: a test of dual-agonist pharmacotherapy for cocaine/heroin polydrug abusersThe neurobiology of modafinil as an enhancer of cognitive performance and a potential treatment for substance use disorders.Wake-promoting pharmacotherapy for psychiatric disorders.The self-medication hypothesis and psychostimulant treatment of cocaine dependence: an updateDopaminergic mediation of the discriminative stimulus functions of modafinil in rats.Modification of cocaine self-administration by buspirone (buspar®): potential involvement of D3 and D4 dopamine receptors.Neuroscience of behavioral and pharmacological treatments for addictionsModafinil effects on reinstatement of methamphetamine seeking in a rat model of relapse.Behavioral evaluation of modafinil and the abuse-related effects of cocaine in rhesus monkeys.A multistudy analysis of the effects of early cocaine abstinence on sleepAdvantages of Joint Modeling of Component HIV Risk Behaviors and Non-Response: Application to Randomized Trials in Cocaine-Dependent and Methamphetamine-Dependent Populations.
P2860
Q21129426-111B9256-1430-4434-8149-E3403914D012Q22242633-CDD018AA-4E13-4193-9C36-0CC259041309Q24607038-6B9C6361-D431-46C0-9A9A-4B9695223403Q24608414-EA9F4998-E2F4-4B8B-BDA0-A3B83CF1861EQ24608557-8F1CA756-5333-4597-99FF-C2796DE605DAQ24631230-60DCB04B-C69C-4AEE-B557-B8A9EAFA2ECEQ26749602-E9CA45A8-BA08-43B5-9853-901410DCE90FQ26829186-D5C563BE-DBF5-4987-89D2-79C59312D97EQ26829749-17BD4DCB-AF76-42D7-B2F0-CB5111D13A91Q26996339-3125FC7E-AB38-46D8-9CB6-2B4B8046D6F6Q27013753-273ABAFB-98EF-4802-A37F-16C029226E8FQ27014854-495706FB-2DDD-4F8A-8F16-9B14A22E9468Q27027961-21C1AF3C-20B5-4D80-8AB1-034B22978FE7Q28267550-C33A29C2-E4A6-48E2-8496-1579342B5354Q30377582-7615D90A-CDDC-47F0-9F9B-D3CFAEEBA9FCQ30413718-B3B67C6B-FB96-4792-9792-1CB105CC0AE7Q30462673-10ACAC93-DFCD-4B10-9C9A-291871A90081Q30653279-4187C90C-EBDE-4BCF-9E62-757E31E7D20EQ33547418-F059A053-8C98-4BC2-AEDE-1BB1ED2FB9B8Q33632279-2D85F22B-9A25-4582-B2F1-EDC61CBA3617Q33873511-7E880510-4087-4CBC-B5CD-480CE1111D7CQ33906303-42B4B874-4FCF-45AC-90FB-E4819B0839D6Q33997733-056D0E06-7444-492A-8B4C-78782734D368Q33998159-C18B9366-3C8A-432D-B607-1D7BDA290DEEQ34065088-7AC2E178-750B-4805-B4AB-855AE2B30DF7Q34091611-DACFC381-032D-4DB0-AE8C-29F0E54B5408Q34183988-BF1B62E1-87E3-45CC-9EAC-609F00F1D793Q34253787-29C3BF23-F422-4F6B-BC6F-5B05DB138ACFQ34256300-86B3FF92-4A22-470C-807F-C61AD33163EBQ34300251-99DD4928-1635-43C4-9275-0800994FFC62Q34363257-12E21AE5-BE20-4E27-9839-E73F7E0A547BQ34443394-0D17D591-FF82-4703-8927-F8CE856C37A5Q34487773-504E1513-8E71-496E-93A9-E7A840C44C84Q34494307-387A42A3-6507-4C84-BFF9-B282EB6CA524Q34640741-B2542DD5-D76D-4D7B-B094-84351AD2750BQ34714494-424B0F51-979F-40C1-871A-986E4B88C0E1Q34795068-76DF0B2A-78FD-4266-AE29-AEF9A1FA0C7FQ34817123-38C2F22F-7919-40E7-8C75-27C66FA6FF94Q34851016-CC115078-A5E1-417A-BA9F-71B3D0B74C40Q35098069-F6A9ED07-2822-4297-BE33-1AF9D5024AC4
P2860
description
2009 nî lūn-bûn
@nan
2009 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Modafinil for the treatment of cocaine dependence
@ast
Modafinil for the treatment of cocaine dependence
@en
Modafinil for the treatment of cocaine dependence
@nl
type
label
Modafinil for the treatment of cocaine dependence
@ast
Modafinil for the treatment of cocaine dependence
@en
Modafinil for the treatment of cocaine dependence
@nl
prefLabel
Modafinil for the treatment of cocaine dependence
@ast
Modafinil for the treatment of cocaine dependence
@en
Modafinil for the treatment of cocaine dependence
@nl
P2093
P2860
P3181
P1476
Modafinil for the treatment of cocaine dependence
@en
P2093
Ahmed M Elkashef
April Slee
Charles Dackis
Edwina V Smith
Eugene Somoza
Frank Vocci
Harold C Urschel
Ihsan M Salloum
John D Roache
Lynn Shemanski
P2860
P304
P3181
P356
10.1016/J.DRUGALCDEP.2009.04.015
P407
P577
2009-06-26T00:00:00Z